References
1. Skolnik, K., G. Kirkpatrick, and B.S. Quon, Nontuberculous
Mycobacteria in Cystic Fibrosis. Curr Treat Options Infect Dis, 2016.8 (4): p. 259-274.
2. Floto, R.A., et al., US Cystic Fibrosis Foundation and European
Cystic Fibrosis Society consensus recommendations for the management of
non-tuberculous mycobacteria in individuals with cystic fibrosis.Thorax, 2016. 71 Suppl 1 : p. i1-22.
3. Adjemian, J., K.N. Olivier, and D.R. Prevots, Epidemiology of
Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients
with Cystic Fibrosis in the United States, 2010-2014. Ann Am Thorac
Soc, 2018. 15 (7): p. 817-826.
4. Aiello, T.B., et al., Prevalence and clinical outcomes of
nontuberculous mycobacteria in a Brazilian cystic fibrosis reference
center. Pathog Dis, 2018. 76 (5).
5. Gardner, A.I., et al., Epidemiology of Nontuberculous
Mycobacteria Infection in Children and Young People With Cystic
Fibrosis: Analysis of UK Cystic Fibrosis Registry. Clin Infect Dis,
2019. 68 (5): p. 731-737.
6. Roux, A.L., et al., Multicenter study of prevalence of
nontuberculous mycobacteria in patients with cystic fibrosis in france.J Clin Microbiol, 2009. 47 (12): p. 4124-8.
7. Adjemian, J., K.N. Olivier, and D.R. Prevots, Nontuberculous
mycobacteria among patients with cystic fibrosis in the United States:
screening practices and environmental risk. Am J Respir Crit Care Med,
2014. 190 (5): p. 581-6.
8. Adjemian, J., et al., Spatial clusters of nontuberculous
mycobacterial lung disease in the United States. Am J Respir Crit Care
Med, 2012. 186 (6): p. 553-8.
9. Cystic Fibrosis Foundation Patient Registry Annual Data
Report. 2018.
10. Cystic-Fibrosis-Foundation-Patient-Registry. Cystic Fibrosis
Foundation Patient Registry Annual Data Report . 2017.
11. Yousef S, S.P., Baker D, Della Volpe A, Colin A, Quizon A,Prevalence of non-tuberculous mycobacteria (NTM) in pediatric
patients with cystic fibrosis (CF) in Florida – A two center study.Paediatr Respir Rev, 2013. 14 (Supp 2): p. S72.
12. Griffith, D.E., et al., An official ATS/IDSA statement:
diagnosis, treatment, and prevention of nontuberculous mycobacterial
diseases. Am J Respir Crit Care Med, 2007. 175 (4): p. 367-416.
13. Ratnatunga, C.N., et al., The Rise of Non-Tuberculosis
Mycobacterial Lung Disease. Frontiers in Immunology, 2020. 11 .